Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.16B |
| 2 |
Hershey
HSY
|
+$663M |
| 3 |
Lockheed Martin
LMT
|
+$622M |
| 4 |
Altria Group
MO
|
+$525M |
| 5 |
Pfizer
PFE
|
+$499M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.76B |
| 2 |
Merck
MRK
|
+$2.35B |
| 3 |
Automatic Data Processing
ADP
|
+$1.57B |
| 4 |
Blackstone
BX
|
+$1.38B |
| 5 |
Illinois Tool Works
ITW
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.85% |
| 2 | Financials | 12.71% |
| 3 | Healthcare | 11.72% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Industrials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
Coherus Oncology
CHRS
$217M
| $1.65M | ﹤0.01% |
689,126
-78,571
| -10% | -$193K |
|
2652
Mitek Systems
MITK
$754M
| $1.64M | ﹤0.01% |
116,571
-2,356
| -2% | -$28.9K |
|
2653
Senseonics Holdings Inc
SENS
$263M
| $1.64M | ﹤0.01% |
154,363
+4,400
| +3% | +$51K |
|
2654
Deutsche Bank
DB
$69B
| $1.62M | ﹤0.01% |
103,019
+24,394
| +31% | +$334K |
|
|
EU
2655
enCore Energy
EU
$212M
| $1.62M | ﹤0.01% |
370,425
+31,073
| +9% | +$132K |
|
2656
Perella Weinberg Partners
PWP
$1.29B
| $1.62M | ﹤0.01% |
114,670
-2,235
| -2% | -$28.1K |
|
2657
NovaGold Resources
NG
$2.56B
| $1.62M | ﹤0.01% |
539,567
-23,636
| -4% | -$66.6K |
|
2658
Cabaletta Bio
CABA
$437M
| $1.6M | ﹤0.01% |
93,525
-2,785
| -3% | -$59.8K |
|
|
GBIO
2659
DELISTED
Generation Bio
GBIO
| $1.58M | ﹤0.01% |
38,926
+778
| +2% | +$18.3K |
|
2660
LanzaTech
LNZA
$61.2M
| $1.58M | ﹤0.01% |
5,112
-34
| -0.7% | -$12.6K |
|
2661
Takeda Pharmaceutical
TAK
$54.6B
| $1.58M | ﹤0.01% |
113,767
+60,323
| +113% | +$877K |
|
2662
eGain
EGAN
$187M
| $1.58M | ﹤0.01% |
244,390
| – | – |
|
2663
Barclays
BCS
$92.7B
| $1.57M | ﹤0.01% |
166,483
+70,592
| +74% | +$578K |
|
2664
Granite Ridge Resources
GRNT
$627M
| $1.57M | ﹤0.01% |
240,924
-472
| -0.2% | -$2.77K |
|
2665
Mineralys Therapeutics
MLYS
$2.25B
| $1.56M | ﹤0.01% |
120,862
-10
| -0% | -$123 |
|
2666
Evolus
EOLS
$385M
| $1.55M | ﹤0.01% |
110,686
-4,093
| -4% | -$53.2K |
|
2667
Precigen
PGEN
$2.24B
| $1.55M | ﹤0.01% |
1,068,527
+59,109
| +6% | +$84.9K |
|
2668
Lloyds Banking Group
LYG
$89.5B
| $1.55M | ﹤0.01% |
597,057
+197,878
| +50% | +$454K |
|
|
EGLE
2669
DELISTED
Eagle Bulk Shipping Inc.
EGLE
| $1.54M | ﹤0.01% |
24,730
-458
| -2% | -$26.7K |
|
2670
Ouster
OUST
$2.63B
| $1.54M | ﹤0.01% |
194,019
+5,725
| +3% | +$32.6K |
|
2671
Ardmore Shipping
ASC
$710M
| $1.54M | ﹤0.01% |
93,814
-3,538
| -4% | -$56.3K |
|
2672
Miller Industries
MLR
$573M
| $1.52M | ﹤0.01% |
30,294
-656
| -2% | -$28.6K |
|
2673
Nature's Sunshine
NATR
$354M
| $1.51M | ﹤0.01% |
72,760
| – | – |
|
2674
SkyWater Technology
SKYT
$1.6B
| $1.49M | ﹤0.01% |
146,644
-4,322
| -3% | -$42.5K |
|
2675
Microvast
MVST
$269M
| $1.49M | ﹤0.01% |
1,778,340
+36,460
| +2% | +$32.5K |
|
Similar funds
Charles Schwab's Q1 2024 Portfolio in Review
As of Q1 2024, Charles Schwab held 3,573 positions worth $433B, up 10% from $394B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 3.8%. Charles Schwab opened 35 new positions and exited 102, leaving the 3,573-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2024 buy was Schwab Fundamental US Large Company Index ETF: 3,608,604 shares worth $81.1M.
- Charles Schwab added most to Bristol-Myers Squibb in Q1 2024, an estimated $2.16B increase.
- Charles Schwab's biggest Q1 2024 reduction was Broadcom, cutting an estimated $2.76B.
- Charles Schwab fully exited Splunk Inc in Q1 2024, selling an estimated $104M.
- Charles Schwab's ten largest holdings make up 20% of its $433B portfolio in Q1 2024.
- Charles Schwab opened 35 new positions and closed 102 in Q1 2024.
- Charles Schwab's portfolio value rose 10% quarter-over-quarter to $433B.
Based on Charles Schwab's 13F filing for Q1 2024, filed 9 May 2024.